SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) December 23, 2002
BIO-RAD LABORATORIES, INC.
_________________________________________________________________
(Exact Name of Registrant as Specified in Charter)
A Delaware Corporation 1-7928 94-1381833
_________________________________________________________________
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
1000 Alfred Nobel Drive, Hercules, California 94547
_________________________________________________________________
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (510)724-7000
No Change
_________________________________________________________________
(Former Name or Former Address, if Changed Since Last Report)
ITEM 5. OTHER EVENTS.
On December 23, 2002, Bio-Rad Laboratories, Inc. ( Bio-Rad ),
issued a press release, the text of which is attached hereto
as Exhibit 99.1, announcing executive management transition plans.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
99.1 Press Release dated December 23, 2002 referred to in
Item 5 above.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
BIO-RAD LABORATORIES, INC.
(Registrant)
Date: December 23, 2002 By: /s/ James R. Stark
James R. Stark
Corporate Controller